In colon cancer, a mechanism by which RAS accelerates tumorigenesis is via AKT‐mediated modulation of β‐catenin's degradation, and increasing levels of cytosolic β‐catenin and canonical WNT/β‐catenin pathway activation. The gene discussed is AKT1; the disease is malignant colon neoplasm.